Australia's Neurotech International Limited (ASX: NTI) has reported final results of in-vitro studies indicate its DOLCE/NTI cannabis strains exhibit potent anti-inflammatory activity. Neurotech acquired an...

The state governments of New South Wales and Tasmania in Australia have signed a Memorandum of Understanding (MoU) relating to collaboration on clinical trials,...

The psychoactive cannabinoid THC has shown promise in slowing mental decline that can affect up to half of HIV patients. It's thought that cognitive function...

An ASX-listed company's subsidiary has been granted an industrial hemp licence - but it's not in Australia. CropLogic Limited (ASX:CLI) says its Oregonian subsidiary...